The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Solutions Market Research Report 2024
Synopsis
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The global Intravenous Solutions market was valued at US$ 11000 million in 2023 and is anticipated to reach US$ 16960 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions.
Report Scope
The Intravenous Solutions market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen
Segment by Type
Crystalloids
Colloids
Others
Segment by Application
Basic IV Solutions
Nutrient Infusion Solution
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Solutions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
The global Intravenous Solutions market was valued at US$ 11000 million in 2023 and is anticipated to reach US$ 16960 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions.
Report Scope
The Intravenous Solutions market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen
Segment by Type
Crystalloids
Colloids
Others
Segment by Application
Basic IV Solutions
Nutrient Infusion Solution
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Solutions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravenous Solutions Market Overview
1.1 Product Overview and Scope of Intravenous Solutions
1.2 Intravenous Solutions Segment by Type
1.2.1 Global Intravenous Solutions Market Value Comparison by Type (2024-2030)
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Intravenous Solutions Segment by Application
1.3.1 Global Intravenous Solutions Market Value by Application: (2024-2030)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Global Intravenous Solutions Market Size Estimates and Forecasts
1.4.1 Global Intravenous Solutions Revenue 2019-2030
1.4.2 Global Intravenous Solutions Sales 2019-2030
1.4.3 Global Intravenous Solutions Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous Solutions Market Competition by Manufacturers
2.1 Global Intravenous Solutions Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous Solutions Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous Solutions Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous Solutions Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Solutions, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Solutions, Product Type & Application
2.7 Intravenous Solutions Market Competitive Situation and Trends
2.7.1 Intravenous Solutions Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Solutions Players Market Share by Revenue
2.7.3 Global Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Solutions Retrospective Market Scenario by Region
3.1 Global Intravenous Solutions Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous Solutions Global Intravenous Solutions Sales by Region: 2019-2030
3.2.1 Global Intravenous Solutions Sales by Region: 2019-2024
3.2.2 Global Intravenous Solutions Sales by Region: 2025-2030
3.3 Global Intravenous Solutions Global Intravenous Solutions Revenue by Region: 2019-2030
3.3.1 Global Intravenous Solutions Revenue by Region: 2019-2024
3.3.2 Global Intravenous Solutions Revenue by Region: 2025-2030
3.4 North America Intravenous Solutions Market Facts & Figures by Country
3.4.1 North America Intravenous Solutions Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous Solutions Sales by Country (2019-2030)
3.4.3 North America Intravenous Solutions Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Solutions Market Facts & Figures by Country
3.5.1 Europe Intravenous Solutions Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous Solutions Sales by Country (2019-2030)
3.5.3 Europe Intravenous Solutions Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Solutions Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Solutions Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous Solutions Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous Solutions Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Solutions Market Facts & Figures by Country
3.7.1 Latin America Intravenous Solutions Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous Solutions Sales by Country (2019-2030)
3.7.3 Latin America Intravenous Solutions Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Solutions Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Solutions Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous Solutions Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous Solutions Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Solutions Sales by Type (2019-2030)
4.1.1 Global Intravenous Solutions Sales by Type (2019-2024)
4.1.2 Global Intravenous Solutions Sales by Type (2025-2030)
4.1.3 Global Intravenous Solutions Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Solutions Revenue by Type (2019-2030)
4.2.1 Global Intravenous Solutions Revenue by Type (2019-2024)
4.2.2 Global Intravenous Solutions Revenue by Type (2025-2030)
4.2.3 Global Intravenous Solutions Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Solutions Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous Solutions Sales by Application (2019-2030)
5.1.1 Global Intravenous Solutions Sales by Application (2019-2024)
5.1.2 Global Intravenous Solutions Sales by Application (2025-2030)
5.1.3 Global Intravenous Solutions Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Solutions Revenue by Application (2019-2030)
5.2.1 Global Intravenous Solutions Revenue by Application (2019-2024)
5.2.2 Global Intravenous Solutions Revenue by Application (2025-2030)
5.2.3 Global Intravenous Solutions Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Solutions Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Intravenous Solutions Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Kelun Group
6.2.1 Kelun Group Corporation Information
6.2.2 Kelun Group Description and Business Overview
6.2.3 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kelun Group Intravenous Solutions Product Portfolio
6.2.5 Kelun Group Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fresenius Kabi Intravenous Solutions Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Otsuka
6.4.1 Otsuka Corporation Information
6.4.2 Otsuka Description and Business Overview
6.4.3 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Intravenous Solutions Product Portfolio
6.4.5 Otsuka Recent Developments/Updates
6.5 ICU Medical
6.5.1 ICU Medical Corporation Information
6.5.2 ICU Medical Description and Business Overview
6.5.3 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ICU Medical Intravenous Solutions Product Portfolio
6.5.5 ICU Medical Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Intravenous Solutions Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 JW Life Science
6.6.1 JW Life Science Corporation Information
6.6.2 JW Life Science Description and Business Overview
6.6.3 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.4.4 JW Life Science Intravenous Solutions Product Portfolio
6.7.5 JW Life Science Recent Developments/Updates
6.8 B. Braun Melsungen
6.8.1 B. Braun Melsungen Corporation Information
6.8.2 B. Braun Melsungen Description and Business Overview
6.8.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2019-2024)
6.8.4 B. Braun Melsungen Intravenous Solutions Product Portfolio
6.8.5 B. Braun Melsungen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Solutions Industry Chain Analysis
7.2 Intravenous Solutions Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Solutions Production Mode & Process
7.4 Intravenous Solutions Sales and Marketing
7.4.1 Intravenous Solutions Sales Channels
7.4.2 Intravenous Solutions Distributors
7.5 Intravenous Solutions Customers
8 Intravenous Solutions Market Dynamics
8.1 Intravenous Solutions Industry Trends
8.2 Intravenous Solutions Market Drivers
8.3 Intravenous Solutions Market Challenges
8.4 Intravenous Solutions Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
